Related by context. All words. (Click for frequent words.) 68 Galectin 3 65 DNA intercalator 64 HDL Mimetic Peptide 64 Squalamine 64 humanized monoclonal 63 antisense inhibitor 63 Trandolapril 63 immunotherapeutic vaccine 63 Epidermal Growth Factor Receptor 63 Modrenal 63 mGluR2 NAM 63 leukotriene pathway 62 intracellular uptake 62 PDE4 inhibitor 62 mediated inhibition 62 Lp PLA 2 62 therapeutic monoclonal antibody 62 cardiac contractility 62 vivo potency 62 Onconase 62 Spiegelmer 62 glucagon receptor 62 A3 adenosine receptor 62 highly selective inhibitor 62 novel peptide 62 therapeutic peptide 62 mecamylamine 62 Bucindolol 62 CCR3 62 inhibitor rofecoxib 62 Cytochrome P# 61 HyACT 61 molecular biomarkers 61 SERMs 61 Glycosylation 61 vidofludimus 61 Ad5FGF 4 61 vascular disrupting agents 61 selective inhibition 61 histone deacetylase inhibitor 61 predictive biomarkers 61 Fenretinide 61 Pentraxin 2 61 cMET 61 small molecule activator 61 HepDirect 61 SGLT 61 Factor VIIa 61 AT1R 61 small molecule activators 61 EGIR 61 prostaglandin synthesis 61 theranostic 61 p# inhibitor 61 delipidation 61 Cardiotoxicity 61 Posiphen 61 Anticalin ® 61 atherosclerosis regression 61 Panzem R 60 TOCOSOL 60 PPARγ 60 rxRNA 60 pharmacological chaperone 60 alagebrium 60 R#/MEM 60 PI3 kinase inhibitors 60 adipogenic 60 Marqibo TM 60 genetic biomarkers 60 kinase pathway 60 Smurf1 60 neuronal nicotinic receptors NNRs 60 antisense inhibitors 60 mTOR mammalian target 60 Stromal 60 Ataluren 60 Fibroblast Growth Factor Receptor 60 protein CETP 60 non nucleoside 60 cobiprostone 60 fosbretabulin 60 Angiolix 60 SGLT2 inhibitors 60 antiproliferative effects 60 cathepsin K inhibitor 60 Panzem ® 60 TH# [003] 60 Varespladib 60 CB2 receptor 60 acadesine 60 protein tyrosine phosphatase 1B 60 DiLA2 60 renin inhibitors 60 galectin 60 CRAC channel 60 endothelial activation 60 Schisandrin B 60 CB1 antagonists 60 Morpholino 60 Darapladib 60 NEUGENE R 60 Locked Nucleic Acid LNA 60 immunoregulatory 60 immunoregulation 60 galectin 3 60 potently inhibit 60 HDL Selective Delipidation 60 Aviptadil 59 DNA methylation markers 59 Inosine 59 alpha#beta# 59 CCR9 59 ONCONASE R 59 ATL/TV# 59 mGlu2 3 59 BXT # 59 novel peptides 59 small molecule modulators 59 Cand5 59 HuLuc# 59 MGd 59 PORxin TM 59 Davanat 59 PI3K/Akt pathway inhibitor 59 biomarker assay 59 NK1 59 immuno modulatory 59 beta 1a 59 Degarelix 59 Vidofludimus 59 selectively inhibiting 59 murine model 59 Technosphere ® 59 preclinically 59 NV1FGF 59 Anticalins ® 59 Aliskiren 59 glucokinase activator 59 Estrogen Receptor 59 HTS assay 59 ARRY # 59 siRNA therapeutic 59 Nanobody ® 59 VEGF receptor 59 A2 Lp PLA2 59 isoform selective 59 FGFR3 59 ImmuKnow R 59 ADAMTS# 59 Panzem 59 Personalized Immunotherapy 59 vivo validation 59 anti CD3 59 diagnostic biomarker 59 CCR1 59 thetreatment 59 RANK ligand 59 cardioprotective effects 59 histone deacetylase HDAC 59 myeloperoxidase 59 P#X# 59 siRNA therapeutics 59 rBChE 59 EP #R 59 DGAT1 59 LPA1 59 telomerase activation 59 RNAi therapeutic targeting 59 Glypromate 59 biologic therapeutics 59 uricase 59 small molecule agonists 59 chemokine receptor 59 Omalizumab 59 gastrin 59 mTOR inhibition 59 PI3K/mTOR 59 midkine 59 nicotinic alpha 7 59 proteasome inhibitors 59 TLE3 59 redox active 59 NexACT ® 58 Corus CAD 58 PKC# 58 tumor hypoxia 58 sd rxRNA 58 thymidylate synthase TS 58 Immunotherapeutic 58 immunostimulatory effects 58 phosphate S1P 58 receptor PPAR 58 depsipeptide 58 SCD1 58 monoclonal antibody mAb 58 Delipidation 58 Neuroprotection 58 chemosensitivity 58 antitumor efficacy 58 G Protein Coupled 58 antiapoptotic 58 Inhalation Solution 58 Symadex 58 VEGF inhibitors 58 chimeric monoclonal antibody 58 GKAs 58 antimitotic 58 investigational therapies 58 LNP formulations 58 GeneICE 58 Dasatinib 58 immune modulating 58 Cystatin C 58 effector function 58 PARP inhibition 58 EGFR HER 58 Mucosal 58 beta1 58 pain palliation 58 Fleximer R 58 atacicept 58 antiplatelets 58 THR beta agonist 58 JAK inhibitor 58 mevalonate 58 GW# [003] 58 thalidomide Thalomid 58 Pyridorin 58 ERK signaling 58 Presents Preclinical Data 58 Oligonucleotide 58 Tß4 58 hERG 58 proteoglycan 58 platelet activation 58 liposomal formulation 58 selective adenosine 58 TAKSTA 58 PPAR gamma agonists 58 adenosine A2A 58 neuro protective 58 Enzastaurin 58 inhibit angiogenesis 58 serine protease 58 tubulin inhibitor 58 lapatinib Tykerb 58 antitumoral 58 kidney urologic 58 rifalazil 58 aerosolized KL4 surfactant 58 mertansine 58 Clusterin 58 Tumor Necrosis Factor 58 RNA antagonist 58 TLR9 agonist 58 vitro assay 58 Calcitonin 58 preclinical efficacy 58 bevacizumab Avastin ® 58 Tarvacin TM 58 BioMAP 58 Initiate Clinical Trial 58 selective modulator 58 anti infective treatments 58 mimetic compounds 58 genomic biomarkers 58 oral salmon calcitonin 58 Posiphen TM 58 γ secretase 58 Osteopontin 58 potency selectivity 58 pharmacodynamic parameters 58 CRD5 58 Aurora Kinase 58 ArQule Kinase Inhibitor Platform 58 investigational humanized monoclonal antibody 58 ENMD # 58 Protein Kinase C 58 azacytidine 58 selective antagonist 58 Retinoic Acid 58 prostanoid 58 phosphatidylinositol 3 58 mda 7 58 novel immunotherapeutic 58 GPx 58 ghrelin antagonist 58 pharmacodynamic PD 58 inosine 58 DNA methyltransferases 58 GSTP1 58 peroxisomal 58 NeoLipid TM 58 cancer immunotherapies 58 thrombin receptor 58 TNFa 58 FGFR 58 HER1 58 RNAi therapeutic targeting PCSK9 58 tkRNAi 58 Cathepsin K 58 alpha#beta# integrin 58 CellCiphr 58 matrix metalloproteases 58 AKIi 5 58 metabolite identification 58 Supernus Pharmaceuticals 58 EnVivo 58 multikinase inhibitor 57 RNA antagonists 57 neuroprotection 57 gefitinib Iressa 57 PPAR γ 57 pharmacologic approaches 57 Liposomal 57 peptide therapeutics 57 intestinal mucosal 57 glucokinase 57 peroxisome proliferator activated 57 epothilones 57 3 kinase PI3K 57 histone deacetylase inhibitors 57 immunotoxins 57 cyclic adenosine monophosphate cAMP 57 tkRNAi technology 57 insulin analogs 57 DXL# 57 Systemic Delivery 57 homotaurine 57 genomic biomarker 57 Cathepsin S 57 gene polymorphisms 57 Zybrestat 57 predictive toxicology 57 ABCG1 57 erythropoietic 57 DGAT 57 mimetics 57 Eli Lilly Cymbalta 57 Cellcept 57 endothelin receptor 57 Azedra 57 selective agonists 57 Phase IIb clinical trials 57 PhG alpha 1 57 NS5A 57 nucleotide analog 57 inflammatory biomarkers 57 anticancer therapeutics 57 humanized monoclonal antibodies 57 Afatinib 57 tafamidis 57 Vidaza azacitidine 57 INS# [001] 57 amyloidogenic 57 Factor VEGF 57 lipid particle 57 CBLC# 57 physiologic mechanisms 57 polyamine 57 RenalGuard Therapy 57 secretory phospholipase A2 sPLA2 57 IL# PE#QQR 57 DNA methylation biomarkers 57 Kinase Inhibitor 57 PDE7 inhibitors 57 Spiegelmer ® 57 Deforolimus 57 PDE# inhibitors 57 mitochondrial toxicity 57 Bioral 57 antithrombotic 57 enzyme inhibitor 57 elastase 57 Curaxin CBLC# 57 HCV protease inhibitors 57 endoglin 57 tramiprosate 57 thyroid hormone receptor 57 Metabolic Disease 57 Muraglitazar 57 TÎ ² 4 57 Cdc7 57 RhuDex 57 Cyclosert 57 immune modulation 57 Cyclosporin 57 tiapamil 57 ON #.Na 57 CINOD 57 biomarker identification 57 Neuroprotective 57 Safinamide 57 Survivin 57 kinase profiling 57 Virulizin ® 57 HCV polymerase 57 inhaled formulations 57 inhibit metastasis 57 cytoprotective 57 induced cytotoxicity 57 Nanobody 57 neuroprotective properties 57 MAGE A3 ASCI 57 IL 1ß 57 tranilast 57 fibrin deposition 57 Novel Oral 57 Tumor Angiogenesis 57 Janus kinase 57 Lenocta 57 interleukin IL -# 57 Androgen Receptor 57 HER2 overexpression 57 VAPRISOL 57 NNRs 57 radiolabeled 57 selectively inhibited 57 aurora kinase 57 carcinoembryonic antigen 57 Archexin 57 Anavex #-# 57 Temsirolimus 57 ATL# [002] 57 multi analyte 57 HSP# inhibitor 57 SinuNase ™ 57 Hematopoietic 57 acetonide FA 57 HCV replication 57 Elafin 57 targeting PCSK9 57 Small Molecule 57 coenzyme Q# CoQ# 57 P2V TM 57 gamma secretase inhibitor 57 Leuprolide 57 PEDF 57 sirtuin therapeutics 57 allosteric modulation 57 Abeta# 57 vivo RNAi 57 BrachySil TM 57 defibrotide 57 Eprodisate 57 MEK inhibitors 57 Initiates Clinical Trial 57 Maxy G# 57 microRNA profiling 57 pan HDAC inhibitor 57 Factor Xa inhibitor 57 clevidipine 57 delta isoform 57 5 HT6 receptor 57 erlotinib Tarceva 57 Xanafide 57 CCX# 57 Parathyroid Hormone 57 BRAF inhibitors 57 FOLOTYN ® 57 LRP5 57 antifibrotic 57 plasma renin activity 57 FGFR1 57 NIC5 57 JAK2 inhibitor 57 NP2 57 prostone 57 monocytes macrophages 57 oxysterols 57 florbetaben 57 factor VIIa 57 ATL# [001] 57 leukocyte adhesion 57 PDGF BB 57 multimodality imaging 57 CobaCyte 57 hPTH #-# 57 Huntexil 57 antiangiogenesis 57 antiangiogenic agent 57 apoB 56 HQK 56 ORE# 56 Tyrima 56 anti dyslipidemic 56 hyaluronidase enzyme 56 Selective Electrochemical Tumor Ablation 56 microtubule inhibitor 56 synthetic lethality 56 TRO# 56 predictive biomarker 56 Arimidex anastrozole 56 Macrophage 56 Novel Small Molecule 56 Myocet 56 CDK inhibitor 56 hypoxic tumors 56 kallikrein 56 Novolimus 56 KL4 surfactant 56 Novasome R 56 AclarusDx ™ 56 orally dosed 56 immunotherapeutics 56 Galectin 56 Myolimus 56 HepDirect prodrug 56 SIRT2 56 TGF β 56 IV Busulfex 56 immune modulatory 56 cannabinoid receptor 56 clinically validated 56 romazarit 56 Catena ® 56 immunomodulating agents 56 MAPK signaling pathway 56 Monocyte 56 p# mitogen activated 56 telomerase inhibitors 56 Cotara ® 56 antitumor effects 56 HER3 56 Endothelin 56 targeted radiotherapeutic 56 deCODE chemistry 56 gene locus 56 immunomodulatory 56 adult mesenchymal stem 56 Preclinical studies suggest 56 CEQ# 56 CCR2 56 throughput RNAi 56 angiogenesis inhibition 56 lipid synthesis 56 metabolite profiling 56 eIF 4E 56 β amyloid 56 Aplidin 56 PPARgamma 56 modulator SERM 56 liposomal delivery 56 MGMT methylation 56 HIF 1α 56 riociguat 56 Factor 5A 56 MAPK pathway 56 targeting CD# 56 ALV# 56 EGFR tyrosine kinase inhibitors 56 GPR# agonists 56 endothelin antagonist 56 tumorigenicity 56 Ozarelix 56 Pterostilbene 56 NuroPro R 56 Genotyping Test 56 biomarker assays 56 Potelligent Technology 56 reslizumab 56 apoptotic pathway 56 protein tyrosine phosphatase 56 NPM1 56 multiplex assay 56 Upregulation 56 prognostic markers 56 GCase 56 Pimavanserin 56 PI3K inhibitor 56 gene expression biomarkers 56 compound AEZS 56 antimetastatic 56 cellular immunotherapy 56 antisense oligonucleotide 56 TPI ASM8 56 chemopreventive agent 56 NPC#L# 56 Quark Biotech Inc. 56 tolerogenic 56 Liprostin 56 cell adhesion molecule 56 Angiocept 56 gastrointestinal absorption 56 vitro ADME 56 potently inhibited 56 ZFP Therapeutic TM 56 VEGF expression 56 lipoprotein metabolism 56 Anticalin R 56 RECOTHROM R 56 Septin 9 56 selective androgen receptor modulators 56 IRX 2 56 KineMed 56 SIRT1 gene 56 pharmacologic intervention 56 Interferon Beta 56 Curaxin 56 Adnectin 56 biased ligand 56 KineMarker TM 56 Tr DNA 56 personalized immunotherapy 56 #F ML 56 Theranostics 56 c MYC 56 Eg5 56 receptor tyrosine kinase inhibitor 56 neuroinflammation 56 immunomodulatory effects 56 intracellular signaling pathways 56 Cardiomyocytes 56 cytochrome P 56 receptor antagonism 56 TPMT 56 indibulin 56 Dual Opioid TM 56 Injectable Suspension 56 ADME properties 56 VerifyNow 56 lucinactant 56 potent antiproliferative 56 MTP inhibitor 56 telomerase inhibitor 56 epigenetic therapies 56 inhibitor RG# 56 Celecoxib 56 Aganocide ® 56 glycogen synthase kinase 56 Chemokine 56 Reports Preclinical Data 56 antiproliferative activity 56 Zysolin TM 56 Yondelis ® 56 Radient Pharmaceutical current 56 gastrointestinal stromal tumors GISTs 56 murine models 56 ERK1 2 56 Anti Tumor 56 CRMD# 56 Matrix metalloproteinase 56 PDGF receptor 56 UsiRNAs 56 siRNAs targeting 56 TLR9 agonists 56 GRNCM1 56 matrix metalloproteinases MMPs 56 cAMP signaling 56 biomarker 56 P selectin 56 Trofex 56 enkephalin 56 selective androgen receptor modulator 56 Epigenomics proprietary 56 inducible nitric oxide synthase 56 Novosom 56 IAP inhibitors 56 EGFR HER2 56 monoclonal antibody therapeutics 56 Treg cell 56 vinca alkaloid 56 MICARDIS ® 56 ALN PCS 56 Vascugel ® 56 FK# 56 XYOTAX TM 56 DepoVax 56 Alequel 56 hexose 56 synthetic siRNA 56 Caprospinol 56 Fibroblast Growth Factor 56 stem cell mobilizer 56 Nedd4 56 Pathway Inhibitor 56 skin sterol 56 product ColonSentry TM 56 intranasal formulation 56 LT NS# 56 validate biomarkers 56 LungExpress Dx 56 #beta HSD1 56 TGF ß 56 Factor Receptor 56 OGG1 56 candesartan cilexetil 56 mTOR kinase 56 inhibit viral replication 56 COX2 56 humanised antibody 56 Lpathomab 55 Bazedoxifene 55 Mammostrat 55 JAK inhibitors 55 Hemopurifier ® 55 PF # [002] 55 AmpliChip 55 vascular disrupting agent 55 osteocalcin protein 55 metabolomic profiling 55 Vaxfectin TM 55 osteogenic 55 #ME# 55 M2 subunit 55 ZFP TF 55 GSK3B 55 HuMax HepC TM 55 Luteinizing Hormone Releasing Hormone 55 serum biomarkers 55 antiarrhythmic 55 Elocalcitol 55 CINQUIL 55 Aethlon Hemopurifier R 55 viral pathogenesis 55 IntroductionThe 55 PI3K delta 55 HDAC6 55 Kinase Inhibitors 55 hedgehog signaling 55 Reductase 55 mechanistic insights 55 antisense oligonucleotides 55 eTag assays 55 oral prodrug 55 humanized antibody 55 histamine dihydrochloride 55 protein misfolding 55 Therapeutic Vaccine 55 Amira Pharmaceuticals 55 mTOR inhibitors 55 proteasome inhibitor 55 Abeta peptide 55 tumor microenvironment 55 chromium supplementation 55 neuroactive 55 receptor monoclonal antibody 55 multicenter Phase II 55 2DG 55 EVIZON TM 55 fatty acid biosynthesis 55 immunomodulation 55 molecular determinants 55 Orally administered 55 histone deacetylase 55 RELOVAIR ™ 55 flavopiridol 55 IL #E 55 anticancer compound 55 Dystrophin 55 Fibroblast 55 hydroxamic acid 55 GAP #B# 55 nicotinic acetylcholine receptor 55 ganaxolone 55 Creabilis Therapeutics 55 Drug Candidate 55 Outpatient Setting 55 VerifyNow P#Y# Test 55 Trophos 55 calcium antagonists 55 molecular chaperone 55 receptor subtypes 55 compound perifosine 55 demethylating agents 55 TGF beta pathway 55 plasmid DNA vaccine 55 nanocarrier 55 transgenic mouse models 55 Silodosin 55 JAK2 Inhibitor 55 Plasmin 55 therapeutic monoclonal antibodies 55 resolvins 55 HSP# inhibitors 55 oral antiplatelet agent 55 HIF PH inhibitors 55 Vascugel 55 NP2 Enkephalin 55 E#F# 55 Genasense ® oblimersen 55 muscarinic 55 PSN# [002] 55 engineered RAP peptides 55 Potent Inhibitor 55 Bruton tyrosine kinase Btk 55 Cytotoxic 55 Hedgehog inhibitor 55 neuroprotectant 55 apoptosis inducing 55 Aganocide 55 deacetylase inhibitors 55 Smac mimetics 55 Monoclonal antibody 55 chimeric antibody 55 beta1 integrin 55 PSMA ADC 55 GPCR targets 55 compound CTCE 55 polysaccharide polymer 55 sipuleucel T 55 targeted antifolate 55 BiTE 55 Tasimelteon 55 naturally occurring molecule 55 MEK inhibitor 55 Peptide YY 55 nasally delivered 55 CYT# potent vascular disrupting 55 selective kinase inhibitors 55 receptor partial agonist 55 JAK Inhibitor 55 murine monoclonal antibody 55 mitogen activated ERK kinase 55 Tyrosine Kinase Inhibitor 55 protein kinase C 55 Recombinant Human 55 JAK3 inhibitor 55 humanized anti 55 antiplatelet therapies 55 Phase 1a clinical 55 molecularly targeted 55 IMiD 55 beta interferons 55 bioactive lipids 55 sodium glucose transporter 55 potent anticancer 55 immunomodulatory properties 55 theranostics 55 metabonomics 55 Sphingomab 55 Psynova 55 pertussis toxin 55 Serdolect ® 55 MUC1 * 55 Virulizin R 55 antiangiogenic drugs 55 SOCS3 55 Bryostatin 55 Anticancer Agent 55 SCIB1 55 Triapine R 55 ImmuneY2 55 antiangiogenic 55 pharmacogenetic 55 FM VP4 55 TGF alpha 55 angiogenesis inhibitor 55 Analogs 55 Initiates Clinical 55 radioimmunotherapy RIT 55 Bioavailability 55 CTGF 55 Preclinical Study 55 renoprotective 55 ProMune 55 NeuroSTAT ® 55 phosphorylated tau 55 Cannabinoid 55 aerosolized surfactant 55 p# INK4a 55 clusterin 55 LDL cholesterol lowering 55 AMPK activators 55 Pitavastatin 55 adrenergic regulation 55 LAB CGRP 55 beta3 55 cathepsin K 55 mGluR5 inhibition 55 homocysteine assay 55 fibrogenesis 55 BRAF inhibitor 55 Aurora kinase 55 androgen receptor AR 55 acamprosate prodrug 55 adalimumab Humira 55 PCK# 55 anti CD3 antibody 55 pharmacodynamic markers 55 Neuropeptide Y 55 NS#/#A protease 55 ATTR CM 55 osteoblast differentiation 55 ESBA# 55 Bone Morphogenetic Protein 55 DNA methylation biomarker 55 A2A receptor 55 vivo gene silencing 55 Guanilib 55 breast cancer metastasis 55 Fc receptor 55 topoisomerase II inhibitor 55 heparanase 55 R roscovitine 55 VitiGam 55 Enzyme Replacement Therapy 55 Thrombin Receptor Antagonist 55 platelet activating 55 Elagolix 55 Zenapax 55 OTCBB CVBT 55 immune modulator 55 NEUGENE 54 enzyme cofactor 54 ALN TTR 54 pharmacodynamic properties 54 biologic pathways 54 P#Y# [001] 54 cannabinor 54 Cardio Vascu Grow 54 tissue oxygenation 54 Lp PLA2 54 oncolytic virus 54 keratinocyte 54 VE cadherin 54 brivaracetam 54 PGx 54 preclinical pharmacokinetic 54 annexin 54 E3 ligase 54 Nuclear Receptors 54 Artelon ® 54 wilate ® 54 5 HT2A 54 plasma pharmacokinetics 54 Removab 54 lipid nanoparticle LNP 54 5 HT2C 54 mTOR inhibitor 54 M1 muscarinic 54 vorinostat 54 KRN# 54 rNAPc2 54 Cetrorelix 54 Trodusquemine MSI 54 Anticalins R 54 Erbitux cetuximab 54 5 HT4 54 Nanobody R 54 hematopoietic progenitor cells 54 Proxinium TM 54 Cloretazine 54 eligen 54 PI3K inhibitors 54 RNAi Therapeutic 54 mucoregulator 54 2 methoxyestradiol 54 molecularly targeted therapy 54 Bevasiranib 54 ZACTIMA 54 OMP #M# 54 LibiGel ® 54 efficacy tolerability 54 humoral responses 54 systemic immunosuppressive drugs 54 IAP inhibitor 54 Inc. Nasdaq ALNY 54 inhibits protein synthesis 54 IL6 54 Phase #b/#a clinical 54 selective kinase inhibitor 54 AEG# 54 PTP 1B 54 vimentin 54 MGN# 54 Xcytrin R 54 CaPre TM 54 OXIGON TM 54 VeriStrat 54 anti angiogenic drugs 54 photodisinfection 54 induces apoptosis 54 alpha fetoprotein AFP 54 HER2 HER3 54 Annexin V 54 CXCR7 54 JAK3 54 CEACAM1 54 S1P 54 NanoCrystal Technology 54 Pharmacokinetic studies 54 zoledronic acid Zometa 54 L BLP# 54 Initiates Enrollment 54 potent cytotoxic 54 thedevelopment 54 Eribulin 54 CINTREDEKIN BESUDOTOX 54 cytotoxic effects 54 oral leukoplakia 54 antioxidant supplementation 54 DCVax 54 methylation markers 54 Akt inhibitor 54 Aplidin R 54 candidate deforolimus 54 prophylactic vaccine